City

New York (2)

Boston (1)

Indianapolis (1)

Overall Status

Completed (1)

Recruiting (1)

Terminated (1)

Sign in for free

Phase

n/a (1)

phase 1 (1)

Sponsor

General Oncology, Inc. (1)

Indiana University (1)

Memorial Sloan Kettering Cancer Center (1)

Collaborator

Amgen (1)

Myriad Genetics, Inc. (1)

Pfizer (1)

Intervention

autologous hematopoietic stem cells (1)

bcnu (1)

epirubicin, cyclophosphamide, paclitaxel, (1)

ethanol (1)

melphalan (1)

vitamin b12b (1)

vitamin c (1)

Study Documents

Intervention Type

drug (2)

device (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (2)

Observational (1)

adenocarcinoma of the breast

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

Recruiting

Pancreatic Adenocarcinoma Metastatic
+14 more

Melphalan
+5 more

Boston, Massachusetts
+1 more

Dec 6, 2022

Breast Cancer, Adenocarcinoma of the Breast Trial in New York (epirubicin, cyclophosphamide, Paclitaxel,)

Completed

Breast Cancer
Adenocarcinoma of the Breast

epirubicin, cyclophosphamide, Paclitaxel,

New York, New York

Memorial Sloan Kettering Cancer Center

Dec 21, 2015

Identification of Novel Biomarkers

Terminated

Adenocarcinoma of the Breast

Indianapolis, Indiana

Indiana University Hospital

Mar 27, 2012